Life Sciences

AI is revolutionizing life sciences, advancing our understanding of nature and driving groundbreaking progress in the discovery, design, development, and manufacturing of new biologic interventions. Its application will accelerate innovation, creating new paradigms for recovering and preserving human health, and fundamentally reshaping how we engineer the world around us. We back founders at the forefront of this evolution, leveraging computational intelligence to shape the future of life sciences.

Explore our Life Sciences portfolio

Antiverse

Combining AI and wet lab biology to design de novo antibodies for challenging GPCR targets implicated in cancer and immune diseases.

CATEGORY

Life Sciences

STATUS

Private

LOCATION

Cardiff, Wales, UK

INNOSPARK TEAM

RELATED ARTICLES & NEWS

Arrepath

Anti-infective discovery platform coupling cell imaging with machine learning analysis to identify new drug candidates and new mechanisms of action.

CATEGORY

Life Sciences

STATUS

Private

LOCATION

Princeton, NJ

BioIntelligence

Improving biomanufacturing across several domains by enabling advanced process control of high-variation fermentation processes, therefore generating better yields.

CATEGORY

Life Sciences

STATUS

Private

LOCATION

Sherbrooke, QC

INNOSPARK TEAM

Encora

Wearable device delivering AI-informed vibrational neurostimulation to sense & reduce tremors in real time for Parkinson’s & Essential Tremor patients.

CATEGORY

Life Sciences

STATUS

Private

LOCATION

Cambridge, MA

INNOSPARK TEAM

Ilios Therapeutics

A biopharmaceutical company discovering and developing rationally-designed multi-targeted therapeutics to combat neurodegenerative diseases.

CATEGORY

Life Sciences

STATUS

Private

LOCATION

Cambridge, MA

INNOSPARK TEAM

Javelin Biotech

Microphysiological systems combining organs-on-chips, multi-omic analysis, and AI-driven modeling to accelerate drug discovery and development.

CATEGORY

Life Sciences

STATUS

Private

LOCATION

Woburn, MA

Odaia

AI-driven SaaS platform creating more targeted, impactful engagement between healthcare providers and pharma sales teams.

CATEGORY

Life Sciences

STATUS

Private

LOCATION

Toronto, ON

INNOSPARK TEAM

Olaris Therapeutics

Precision diagnostics platform combining metabolomics with machine learning to predict biomarkers response that help optimize treatment outcomes.

CATEGORY

Life Sciences

STATUS

Private

LOCATION

Framingham, MA

INNOSPARK TEAM

Persist AI

Machine Learning powered platform that predicts extended-release formulations for any drug, enabling generics manufacturers to get XR formulations to market.

CATEGORY

Life Sciences

STATUS

Private

LOCATION

West Sacramento, CA

INNOSPARK TEAM

RELATED ARTICLES & NEWS

STRM.bio

Leveraging AI and extracellular vesicles (EVs) to deliver gene therapy in a simpler, safer, and more practical way.

CATEGORY

Life Sciences

STATUS

Private

LOCATION

Cambridge, MA

Via Scientific

Enabling biologists to perform routine bioinformatics analysis independently, without the need to consult bioinformaticians.

CATEGORY

Life Sciences

STATUS

Private

LOCATION

Cambridge, MA

INNOSPARK TEAM